Teva Pharmaceuticals USA, Inc. v. Superior Court

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• relying on Fulgenzi to hold failure-to-warn claim not preempted when generic manufacturers of alendronate sodium did not mirror the branded Fosamax label
• relying on Fulgenzi to hold failure-to-warn claim not preempted when generic manufacturers of alendronate sodium did not mirror the branded Fosamax label
• federal preemption does not bar suit against a generic-brand-name manufacturer who failed to conform to a change in the brand-name manufacturer’s label
• after collecting and summarizing federal district court and state court cases reaching the same decision as the Sixth Circuit, California Court of Appeals expressly stated its disagreement with the Fifth Circuit

Source: CourtListener parenthetical corpus (CC0).